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Abstract
Our understanding of neural circuits--how they mediate the computations that subserve sensation, thought, emotion, and action, and how they are
corrupted in neurological and psychiatric disorders--would be greatly facilitated by a technology for rapidly targeting genes to complex
3-dimensional neural circuits, enabling fast creation of "circuit-level transgenics." We have recently developed methods in which viruses encoding
for light-sensitive proteins can sensitize specific cell types to millisecond-timescale activation and silencing in the intact brain. We here present the
design and implementation of an injector array capable of delivering viruses (or other fluids) to dozens of defined points within the 3-dimensional
structure of the brain (Figure. 1A, 1B). The injector array comprises one or more displacement pumps that each drive a set of syringes, each of
which feeds into a polyimide/fused-silica capillary via a high-pressure-tolerant connector. The capillaries are sized, and then inserted into, desired
locations specified by custom-milling a stereotactic positioning board, thus allowing viruses or other reagents to be delivered to the desired set of
brain regions. To use the device, the surgeon first fills the fluidic subsystem entirely with oil, backfills the capillaries with the virus, inserts the device
into the brain, and infuses reagents slowly (<0.1 microliters/min). The parallel nature of the injector array facilitates rapid, accurate, and robust
labeling of entire neural circuits with viral payloads such as optical sensitizers to enable light-activation and silencing of defined brain circuits. Along
with other technologies, such as optical fiber arrays for light delivery to desired sets of brain regions, we hope to create a toolbox that enables the
systematic probing of causal neural functions in the intact brain. This technology may not only open up such systematic approaches to
circuit-focused neuroscience in mammals, and facilitate labeling of brain regions in large animals such as non-human primates, but may also open
up a clinical translational path for cell-specific optical control prosthetics, whose precision may enable improved treatment of intractable brain
disorders. Finally, such devices as described here may facilitate precisely-timed fluidic delivery of other payloads, such as stem cells and
pharmacological agents, to 3-dimensional structures, in an easily user-customizable fashion.
Protocol
1. Constructing Stereotaxic Clamp
2. Preparing the system for the customized injector array: Hamilton pump and stereotax
3. Constructing the Customized Injector Array
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1. The stereotaxic clamp is used for attaching the injector array to the stereotax, so that the injectors are parallel to the stereotaxic arm.
2. Each lab needs only one clamp, unless it is anticipated that more than one surgery may take place simultaneously. In this case, make the
same number as the anticipated maximum number of simultaneous surgeries. It might also be advisable to make an extra, in case of damage
to the first.
3. To make the stereotaxic clamp, firstly, a 1.5 mm outer diameter (OD) steel cannula is cut to 2 inches in length, and one of the ends is
Dremeled down until flat.
4. Next, a small piece (approximately 0.5 x 0.5 cm) is cut out of PCB proto-board, to be used as a spacer.
5. Using a laser cutter to ensure that any cuts made are perpendicular to the surface of the material, two identical rectangles (1/2" x 3/8") are cut
from 1/8" acrylic sheeting, each rectangle having two circular holes in opposite corners of the rectangle. The first hole has diameter 1.5mm,
and is just large enough to hold the metal cannula tightly. The second hole has diameter 1/16" (Figure 1C).
6. The metal cannula is inserted into the 1.5 mm hole of one rectangle, then through the 1.5 mm hole of the second. The bottom end of the
cannula is aligned with the bottom face of the bottom rectangle, forming the shape of a hockey stick.
7. While keeping the spacer tightly held between the two rectangles, this structure is cemented together by using hot glue around the cannula
and 1.5mm holes, being careful to avoid gluing the spacer to the rectangles. Modeling clay may be helpful to hold things together during this
process.
8. After the glue has dried, a 1-72 screw is inserted into the 1/16 hole from the top side of the rectangles. Then a 1-72 hex nut is screwed onto
the end of the 1-72 screw, and tightened. The screw and nut serve to hold the clamp together.
9. To attach the hex nut to the bottom face of the bottom rectangle, small amounts of 5-minute epoxy are dropped around the edge of the hex
nut, without allowing the epoxy to get into the threads of the hex nut or screw. Any modeling clay is removed, and it is confirmed that the
spacer can be held firmly in place by tightening the screw.
1. The injector array system can be customized to virtually any set of coordinates in the brain.
2. The user first locates coordinates of desired injection sites in a mouse (or other species) brain atlas, converting to the appropriate coordinates
used by the stereotax (here, X-, Y-, and Z-coordinates). The number of injection sites (three in Figures 1A and 1B) will hereafter be called k.
3. k number of 10 μl Hamilton syringes are placed in an injection/withdrawal syringe pump such as this one from Harvard apparatus.
4. Next, 3-foot-long pieces of polyethylene tubing are securely attached to the needle of each Hamilton syringe.
5. For each piece of polyethylene tubing, an F-252 tubing sleeve from Upchurch Scientific is slid over the open end and attached to a P-627
tubing adapter using the included nut and ferrule, also from Upchurch Scientific.4. Assembling the entire system
5. Injections/surgery
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1. Each injector array is customized to the set of coordinates that the user chooses. However, for sets of coordinates that differ only by a
translation and/or rotation, the same injector array can be used.
2. Considering only the relative X and Y coordinates of the injection sites, k holes are drilled into a PCB proto-board of thickness 1/32", with the
same relative spacing. These holes are drilled using a Modela mini mill and a .011" diameter drill bit from Mcmaster-Carr. Be sure to use a
slow rate of drilling (Z-speed) to avoid breaking or wearing out the drill bit. Before removing the board from the mill, a rectangle is drilled
around the small holes, using a larger drill bit of diameter 1/32", to avoid wearing out the smaller one. Code for the mini mill can be generated
easily using MATLAB; sample code is provided in the following files.
1. generate.m - MATLAB code for generating Modela code from desired coordinates
2. holes_ex.rml - Modela code for drilling ring pattern (eight holes) into Proto-board
3. outline_ex.rml - Modela code for drilling rectangle around holes
3. 245 μm OD/100 μm inner diameter (ID) fused silica capillary tubing, available from Polymicro Technologies, is cut into k number of 3 inch
pieces. These comprise the individual injectors. A disposable piece of capillary tubing is poked through each of the holes, to clear away debris
without clogging the actual injectors. The injectors are then inserted halfway into each hole, so that they are held tightly and parallel to one
another. The injectors are epoxied to the board, forming the structure of the injector array. All that remains is to trim the injectors to the correct
length.
4. The injector array is attached to the stereotaxic clamp by placing one corner of the proto-board between the acrylic rectangles, and then by
tightening the screw of the stereotaxic clamp. Next, the metal cannula of the clamp is attached to the stereotax, using the attachment
mechanism of the stereotax.
5. All of the following is done under a microscope. For one of the outer injectors (that is, one that can be approached from the side with a
straight edge, without bumping into any of the other injectors), the tip extending beyond the bottom of the proto-board is cut with scissors. For
cortical injections, it is appropriate to have the injector extending approximately 5mm beyond the surface of the proto-board. For deeper
injections, this number can be increased by the corresponding increase in depth. The tip is flattened with a Dremel tool. Injector tips can also
be ground at an angle as an extra precaution against clogging, if precision in depth is less important.
6. Next, a stable reference point is chosen within range of the stereotaxic arm, and the injector array is moved so that the flattened tip of the
outer injector, is at this reference point.
7. A second injector is chosen, along with its corresponding coordinates. Considered is the relative difference in height (z-direction) between the
first and second injector coordinates. The injector array is moved along the Z axis by this relative distance. The second injector is trimmed
and Dremeled to the correct length, so that the tip of the second injector is now flat and at the height of the reference point. The injector array
can be moved in the X and Y directions to facilitate comparison of the injector tip with the reference point.
8. This process of trimming is repeated for the remaining injectors.
1. The stereotaxic clamp and customized injector array, both already constructed, are required for this part.
2. The back end of each injector (the end that has not been trimmed) is inserted into a blue F-240 tubing sleeve and, using a P-235 nut and
P-200 ferrule from Upchurch Scientific, is attached to the threaded adaptor already connected to the Hamilton pump by polyethylene tubing.
Manufacturer’s instructions can be consulted for details.
3. Using a 27-gauge needle, silicone oil is injected into the back of the Hamilton syringes so that the entire system is filled from the Hamilton
syringe to the injector tip, with no air bubbles at all.
4. As the Hamilton syringes are re-placed in the Hamilton pump, the greatest possible volume of silicone oil is maintained in the syringes.
5. If the experiment requires more syringes than the pump is designed for (two in this case), the syringes can be spaced with small pieces of
plastic (e.g., needle caps) to keep them parallel to one another, and to ensure that all pieces are pushed by the pump to the same extent. Or,
a multi-rack upgrade kit can be purchased from Harvard Apparatus to hold up to 10 syringes at once.
1. The process of injecting with a parallel injector is very similar to that of injecting with a single pipette.
2. It is essential to use slow refill/infuse rates throughout this process, because fast pumping might put stress on the joint between large and
small tubing. Recommended max rate: 2 μl/min for loading virus, and 0.1 μl/min for infusing virus.
3. An anesthetized mouse is placed in the stereotax, and remains anesthetized throughout the experiment.
4. Prepare the mouse as needed. For example, with a scalpel, a single cut is made down the midline of the skin, from between the eyes to
between the ears. The skin is pulled back to expose the skull, and the fascia is cleaned off. A pulled glass pipette is attached to the stereotax.
The positions of the ear bars are adjusted until bregma and lambda are aligned to the same height, and so that the line connecting them is
parallel to the Y-axis of the stereotax. The axes of the stereotax are oriented according to the coordinate system in which the injection
coordinates have been calculated. The stereotaxic is zeroed with the tip of the glass pipette at bregma, and then the tip is positioned slightly
above the skull at the X- and Y-coordinates of one of the injection sites.
5. Using a dental drill, the skull below the tip is carefully pared away until there remains an extremely thin layer of bone. The glass pipette can
be lowered and raised to check that the hole being drilled is centered at the correct position. Using a 30-gauge needle, a tiny piece of the
layer is gently picked off, at the correct X- and Y- coordinates, so that the dura mater is exposed. This hole should be just large enough to fit
one of the injectors (0.25mm wide). See Figure 1D for diagram. In this way, small, 0.25mm wide holes are made in the skull, at the X- and Y-
coordinates corresponding to each injection site.
6. The glass pipette is discarded in a sharps container, and the customized injector array is attached to the stereotax using the stereotaxic
clamp.
7. In order to correctly set the angle of the injector array, two outer injectors are chosen to be calibrated to a given reference point, as follows.
After one of the injectors is matched with the reference point, consider the relative X- and Y- distances between the injection sites relative to
this injector and one other. The axes of the stereotax are adjusted so that entire injector array is moved in the X- and Y-directions by these
relative distances. If the second injector is not now aligned with the reference point, the metal cannula is loosened and rotated. This process
is repeated iteratively until the injector array is angled correctly.
8. Before filling the injectors with virus, the injectors are filled with silicone oil until the syringes are at the 2 μl point (or greater). This provides a
buffer zone, so that any air bubbles or clogging in the tip can be easily removed by pushing oil forward using the Hamilton pump, without
having to refill the entire system with silicone oil from the back of the syringes, as describe previously.
9. A sterile piece of Parafilm is placed on the skull, and the injectors are gently lowered onto the Parafilm. For coordinates with greatly varying
depths, a custom-milled part (e.g. a staircase-shaped object) could facilitate loading.6. Representative Results
The parallel injector array speeds up a surgery roughly by a factor equal to the number of injectors, not counting setup and recovery time,
although individual times will depend on the skill of the practitioner. For a 1 microliter injection, we typically saw lentivirus expression in a sphere
of approximately diameter 1mm (Fig. 1E). The precision of the injection was such that the variability in tip positioning, from trial to trial, was about
45 microns (standard deviation of the distance from the tip position to the intended tip position).
Figure 1. Design, implementation, and use of a parallel virus injector array. A, schematic of the parallel injector array system, showing a triple
injector configuration, for three simultaneous injections. B, photograph of a triple parallel injector array as diagrammed in A. C, stereotaxic clamp,
shown in outline from the top. D, illustration of technique for efficient, damage-minimizing, opening of holes in skull for injector insertion into brain:
with a dental drill, thin the skull down to ~50 microns thickness, then use the tip of a sharp needle to open a small craniotomy. E, fluorescence
image showing channelrhodopsin-2 (ChR2)-GFP-labeled cells in three mouse cortical regions, as targeted by the triple injector array shown in B.
Discussion
In recent years, a number of genetically-encoded optical sensitizers have enabled neurons to be activated and silenced in vivo in a
temporally-precise fashion, in response to brief pulses of light (e.g., 1,4,5,6,7,8,11
). A key method with which neurons have been sensitized to light in
the mammalian brain, is via viruses such as lentiviruses and adeno-associated viruses (AAV), which can deliver genes encoding for opsins to
brains of animals ranging from mice to monkeys, in a safe and enduring fashion (e.g., 2,9,10). Viruses allow faster turnaround time than do
transgenics, especially for organisms that are not genetic model organisms such as rats and monkeys, and for opsins may enable high
expression levels that may not be possible in transgenic scenarios. Here we demonstrate a parallel injector array capable of creating, in a rapid
timescale, "circuit-level transgenics," enabling entire 3-dimensional brain structures to be virally targeted with a gene, in a single surgical step.
The injector array comprises one or more displacement pumps that each drive a set of syringes, each of which feeds into a polyimide/fused-silica
capillary via a high-pressure-tolerant connector. The capillaries are sized, and then inserted into, desired locations specified by custom-milling a
stereotactic positioning board, thus allowing viruses or other reagents to be delivered to the desired set of brain regions. To use the device, the
surgeon first fills the fluidic subsystem entirely with oil, backfills the capillaries with the virus, inserts the device into the brain, and infuses
reagents slowly (<0.1 μL/min).
This technology will enable a wide variety of new kinds of experiments, such as millisecond-timescale shutdown of complexly-shaped structures
(such as the hippocampus) at precise times during behavior, temporally-precise inactivation of bilateral structures that may act redundantly (such
as the left and right amygdala), and the perturbation of multiple discrete brain regions (e.g., driving two connected regions out of phase to study
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10. The following parts assume that 1 μl of virus is to be loaded at each site (the following quantities should be scaled down if smaller quantities
are desired). In order to guarantee that >1 μl of virus is injected at each site, 1.5 μl of virus is pipetted onto the Parafilm or staircase at the tip
of each injector.
11. With the refill rate of the Hamilton pump set to 1 μl/min, 1.2 μl of the virus is refilled into each injector.
12. The tip of the longest injector is zeroed at bregma, and then the injector array is shifted to the X- and Y- coordinates of that injector. If clogging
is an issue, say if many deep targets are involved: even before inserting the injector tips into the brain, it is sometimes advisable to start the
pump infusing, until virus can be seen emerging from all the injector tips. This removes any air bubbles at the injector tips, and also ensures
that there is no clogging. In the case of clogging, the Hamilton pump is set to infuse a brief pulse at a higher speed of 2 μl/min, to gently clear
out clogging.
13. The injector array is then lowered, through the small holes made with the 30-gauge needles, to the correct Z-depth.
14. 1 μl of virus is injected through each injector, at 0.1 μl /min.
15. The injections are left alone for 30 minutes.
16. After the injector array is slowly extracted from the brain, the Hamilton pump is set to infuse at the same rate of 0.1 μl /min, in order to check
for clogging in each injector.
17. Then the injectors are cleaned by refilling and infusing 1.5 μl of ethanol at 2 μl/min.
18. Finally, the injectors are refilled with silicone oil to maintain the 2 μl buffer zone in each Hamilton syringe.
19. All equipment should be sterilized before and after the procedure, according to your institution's biosafety and animal use protocols.how cross-region synchrony depends upon activity within each region, or stimulating inputs to a region while silencing a subset of the targets in
order to understand which of the several targets are critical for mediating the effects of those inputs). For large brains like those in the primate, in
which we have recently demonstrated optical cell-type specific neural activation3, perturbing activity in a behaviorally-relevant area may require
viral labeling of large, complex structures. We note that parallel injector arrays may be used to inject almost any payload – drugs,
neuromodulators, neurotransmitters, or even cells – in complex 3-D patterns in the brain, in a temporally-precise manner. Finally, from a
translational standpoint, it is possible that rapid, patient-customized gene therapy or drug delivery devices may be rapidly custom-designed and
fabricated to match individual brain geometries, supporting new treatments for a variety of pathologies, potentially through the use of optical
control molecules.
The injector arrays are designed to be precise, both spatially and volumetrically. In the X- and Y-directions, this is accomplished by drilling very
accurately placed holes using an inexpensive mini-mill, with the holes just large enough to fit the injectors, so that injectors are held parallel to
one another, and in a precise location. In the Z-direction, the injectors are trimmed using a stereotaxic apparatus, allowing a level of precision
equivalent to that of the stereotaxic surgery itself. The volumetric precision arises from the precision of the Hamilton pump, as well as the
near-zero dead-volume connectors, adapted from the high-pressure liquid chromatography (HPLC) field. The injectors are made from fused silica
capillary tubing, which is strong and rigid enough that it maintains precise shape and spacing under pressure, without the larger wall thickness of
alternatives such as steel cannulas. Small modifications can easily be made to adapt the parallel injector array to a variety of experiments. For
example, if a smaller volume of virus or finer spacing is required, smaller capillary tubing can be employed, along with a corresponding smaller
drill bit. Future devices may utilize microfluidic channels and pumps, to increase the number of parallel injectors, to minimize the size (perhaps
enabling such devices to be mounted on the heads of freely-moving animals).
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